Community Schedule

Enter at least 4 characters

1 results showing for: 'sunitinib'

- Special Authority SA2117 -- Retail pharmacy
  • Cap 12.5 mg
    • Brand Fully subsidised brand. Sutent
    • Pharmacode2243962
    • Subsidy $2315.38
    • Measure / Qty per 28
    • Brand Fully subsidised brand. Sunitinib Pfizer
    • Pharmacode2630303
    • Subsidy $208.38
    • Measure / Qty per 28
    Sunitinib Pfizer to be Principal Supply on 1 July 2022
    (Sutent Cap 12.5 mg to be delisted 01 July 2022)
  • Cap 25 mg
    • Brand Fully subsidised brand. Sutent
    • Pharmacode2243970
    • Subsidy $4630.77
    • Measure / Qty per 28
    • Brand Fully subsidised brand. Sunitinib Pfizer
    • Pharmacode2630311
    • Subsidy $416.77
    • Measure / Qty per 28
    Sunitinib Pfizer to be Principal Supply on 1 July 2022
    (Sutent Cap 25 mg to be delisted 01 July 2022)
  • Cap 50 mg
    • Brand Fully subsidised brand. Sutent
    • Pharmacode2243989
    • Subsidy $9261.54
    • Measure / Qty per 28
    • Brand Fully subsidised brand. Sunitinib Pfizer
    • Pharmacode2630338
    • Subsidy $694.62
    • Measure / Qty per 28
    Sunitinib Pfizer to be Principal Supply on 1 July 2022
    (Sutent Cap 50 mg to be delisted 01 July 2022)
SA2117 – Sunitinib
  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply